Reply to: Comments on "Diabetic MAFLD is associated with increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis patients"

被引：0
|
作者：
Kim, Mi Na [1 ,2 ,3 ]
Zhang, Xuehong [4 ,5 ]
Ahn, Sang Hoon [1 ,2 ,3 ]
机构：
[1] Yonsei Univ, Coll Med, Dept Internal Med, 50 Yonsei Ro, Seoul 03722, South Korea
[2] Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul, South Korea
[3] Severance Hosp, Yonsei Liver Ctr, Seoul, South Korea
[4] Harvard T H Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA
[5] Brigham & Womens Hosp, Channing Div Network Med, Dept Med, Boston, MA USA
来源：
INTERNATIONAL JOURNAL OF CANCER | 2024年 / 154卷 / 07期
关键词：
BODY-MASS INDEX; ALL-CAUSE MORTALITY;
D O I：
10.1002/ijc.34797
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1326 / 1327
页数：2
相关论文
共 50 条
  • [1] Diabetic MAFLD is associated with increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis patients
    Kim, Mi Na
    Han, Kyungdo
    Yoo, Juhwan
    Hwang, Seong Gyu
    Zhang, Xuehong
    Ahn, Sang Hoon
    INTERNATIONAL JOURNAL OF CANCER, 2023, 153 (08) : 1448 - 1458
  • [2] Comment on "Diabetic MAFLD is associated with increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis patients"
    Zhao, Gang
    Shi, Xiaobao
    Zhang, Lingyun
    Liang, Hongyuan
    INTERNATIONAL JOURNAL OF CANCER, 2024, 154 (07) : 1324 - 1325
  • [3] DIABETIC METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE IS ASSOCIATED WITH INCREASED RISK OF HEPATOCELLULAR CARCINOMA AND MORTALITY IN CHRONIC VIRAL HEPATITIS PATIENTS
    Kim, Mi Na
    Han, Kyungdo
    Yoo, Juhwan
    Hwang, Seong-Gyu
    Ahn, Sang Hoon
    HEPATOLOGY, 2022, 76 : S244 - S245
  • [4] Increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis with concurrent fatty liver
    Kim, Mi Na
    Han, Kyungdo
    Yoo, Juhwan
    Hwang, Seong Gyu
    Ahn, Sang Hoon
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (01) : 97 - 107
  • [5] CONCURRENT FATTY LIVER IS ASSOCIATED WITH HIGHER RISK OF HEPATOCELLULAR CARCINOMA AND MORTALITY IN PATIENTS WITH CHRONIC VIRAL HEPATITIS
    Kim, Mi Na
    Han, Kyungdo
    Yoo, Juhwan
    Hwang, Seong-Gyu
    Ahn, Sang Hoon
    HEPATOLOGY, 2021, 74 : 450A - 450A
  • [6] RISK OF HEPATOCELLULAR CARCINOMA IN CHRONIC VIRAL HEPATITIS
    Kane, Lara J.
    Macdonald, Graeme A.
    CANCER FORUM, 2009, 33 (02)
  • [7] Metabolic dysfunction-associated fatty liver disease subgroups and risk of hepatocellular carcinoma and mortality in patients with chronic viral hepatitis
    Kim, Mi Na
    Han, Kyungdo
    Yoo, Juhwan
    Hwang, Seong Gyu
    Ahn, Sang Hoon
    JOURNAL OF HEPATOLOGY, 2022, 77 : S100 - S100
  • [8] Hepatitis B viremia is associated with increased risk of hepatocellular carcinoma in chronic carriers
    Tang, BQ
    Kruger, WD
    Chen, G
    Shen, FM
    Lin, WY
    Mboup, S
    London, WT
    Evans, AA
    JOURNAL OF MEDICAL VIROLOGY, 2004, 72 (01) : 35 - 40
  • [9] Is Tenofovir Associated with a Lower Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Compared With Entecavir? Reply
    Yip, Terry Cheuk-Fung
    Wong, Grace Lai-Hung
    GASTROENTEROLOGY, 2020, 158 (08) : 2312 - 2313
  • [10] Editorial: concurrent fatty liver and chronic viral hepatitis: a dual calamity leading to increased risk of hepatocellular carcinoma? Authors' reply
    Kim, Mi Na
    Ahn, Sang Hoon
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (04) : 481 - 482
12345